1 research outputs found
Enantiospecific Recognition at the A<sub>2B</sub> Adenosine Receptor by Alkyl 2‑Cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylates
A novel
family of structurally simple, potent, and selective nonxanthine
A<sub>2B</sub>AR ligands was identified, and its antagonistic behavior
confirmed through functional experiments. The reported alkyl 2-cyanoimino-4-substituted-6-methyl-1,2,3,4-tetrahy-dropyrimidine-5-carboxylates
(<b>16</b>) were designed by bioisosteric replacement of the
carbonyl group at position 2 in a series of 3,4-dihydropyrimidin-2-ones.
The scaffold (<b>16</b>) documented herein contains a chiral
center at the heterocycle. Accordingly, the most attractive ligand
of the series [(±)<b>16b</b>, <i>K</i><sub>i</sub> <b>=</b> 24.3 nM] was resolved into its two enantiomers by
chiral HPLC, and the absolute configuration was established by circular
dichroism. The biological evaluation of both enantiomers demonstrated
enantiospecific recognition at A<sub>2B</sub>AR, with the (<i>S</i>)-<b>16b</b> enantiomer retaining all the affinity
(<i>K</i><sub>i</sub> <b>=</b> 15.1 nM), as predicted
earlier by molecular modeling. This constitutes the first example
of enantiospecific recognition at the A<sub>2B</sub> adenosine receptor
and opens new possibilities in ligand design for this receptor